ABSTRACT Peptides that stimulate astroglial proliferation are produced in traumatized adult rat brain by 10 d after injury. These same peptides are released by ameboid microglia activated in vitro. Our findings suggest that astroglial scarring is regulated in part by the release of factors from ameboid microglia near the site of brain injury.
tocerebroside (8) . Cells adhering to coverslips were washed with Dulbecco's minimal essential medium containing 20% heat-inactivated goat serum (GS) and fixed for 30 min at -20"C with 90% acetone/10% acetic acid (vol/vol). The coverlips were dipped sequentially in 100% acetone, 70% ethanol, PBS, and Dulbecco's minimal essential medium with 1% GS. Rabbit anti-human GFAP-antibody (whole serum; Accurate Chemical & Scientific Corp., Westbury, NY) was diluted 1:200 with Dulbecco's minimal essential medium with 1% GS and was applied directly to the covershps. Coverslips were incubated for 45 min at 37"C in 95% air/5% CO2 with high humidity and were washed with Dulbecco's minimal essential medium. A goat anti-rabbit IgG conjugate of rhodamine isothiocyanate (Accurate Chemicals & Scientific Corp.) was diluted to 1:100 with Dulbecco's minimal essential medium-1% GS was next applied for 45 min at 37"C. Coverslips were washed five times with Dulbacco's minimal essential medium-l% GS and distilled H20 and were mounted in glycerol containing 1 mg/ml ofp-phenylenediamine and 10% PBS. Fluorescentlabeled cells were viewed at x 200 with a Nikon Diaphot microscope using epifluorescence. Identification of galactocerebroside-positive oligodendroglia was carded out in a similar fashion with cell fixation after antibody binding. Rabbit anti-galactocerebroside serum, produced in our laboratory, was used with a dilution of 1:100.
Ameboid microgha (12) were isolated from mixed glial cultures grown in 75-cm 2 plastic culture flasks containing 10 ml defined medium with 10% fetal bovine serum at a density of 85,000 cells/ml. After 7 d, confluent cultures were vigorously agitated on a rotary shaker for 15 h (37°C; 180 rpm). The resulting suspension, containing process-bearing cells and mieroglia, was transferred to a new 75-cm 2 culture flask. After a 3-h adhering interval, process-bearing cells were suspended by gently shaking flasks at room temperature. This cell suspension was discarded. Each flask was then treated with 0.2% trypsin in defined medium and vigorously shaken by hand to release adhering microglia. Once the majority of the microglia had been resuspended, fetal bovine serum was added to the defined medium (15% final volume) and the cell suspension added to new plastic flasks. After a second 3-h interval to allow adhesion, the medium was removed, and adhering microglia were resuspended using trypsin. Final preparations showed a nearly homogeneous population with 95% nonspecifie esterase-positive microglia (Giulian, D., and T. J. Baker, unpublished data). There was a 10% recovery of all esterase-positive microglia found in the starting cultures. These ameboid microglia showed the MAC-I and MAC-3 antigens, an ability to engulf 5-urn latex beads, and the presence of the acetylated low density lipoprotein receptor (Giulian, D., and T. J. Baker, unpublished data; see also references 2 and 12). Fixed Staphylococcus aureus in suspension (Pansorbin, Calbiochem-Behring Corp., La Jolla, CA) was used to stimulate microglial secretions (20 ul added per 1.5 ml culture medium). Unlike peripheral blood monocytes, microglia were peroxidase negative and in contrast to THE JOURNAL OF CELL BIOLOGY. VOLUME 101 DECEMBER 1985 2411-2415
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tissue macrophage, microglia proliferated in vitro (Giulian, D., and T. J. Baker, unpublished data; see also references 2 and 12). Microglia could be selectively destroyed using L-leucine methyl ester, a lysosomotrophic agent effective against phagocytic cells (14) .
Isolation of CPFs: Four GPFs have been isolated from goldfish brain (6) (7) (8) (9) . Two of these peptides, GPFt (estimated molecular mass 15 kD) and GPFs (6 kD), acted upon oligodendroglia while GPF2 (9 kD) and GPF4 (3 kD) served as mitogens for astroglia (8) . In this study, we examined GPFs isolated from the brain of rat. Anesthetized adult female rats (Holtzman Co., Madison, WI) received from 10 to 15 puncture wounds in the cerebral cortex to a depth of 3 mm using a 26-gauge needle. The damaged cortex was isolated 10 d after surgery with the contralateral hemisphere providing intact tissue control. Brain samples were dispersed by sonication in ice-chilled PBS and centrifuged at 15,000 g for 30 min. The supernatants were filtered through 0.45-~m filters and applied to a standardized gel filtration column (Bio-Rad Laboratories, Richmond, CA; P-10, 100 x 0.9 cm). Defined culture media conditioned for 24 h by enriched populations of ameboid microglia were concentrated using ultrafiltration (YM-2, Amicon Corp., Danvers, MA) and fractionated by gel filtration as described for brain material. Each fraction was tested for its mitogenic effect upon of oligodendroglia or astroglia. We found that the apparent molecular masses and specificity of biologic activities were the same for GPFs isolated from fish and rat brain (8, 9) . Furthermore, fish and rat GPFs co-porified using ion exchange chromatography and reverse-phase high performance liquid chromatography, which suggests that these factors were structurally similar (Giulan, D., and T. J. Baker, unpublished data; see also references 8 and 9). GPFs in brain supernatants from injured and intact adult rats or conditioned media from activated and control microglia were separated by consecutive column elutions. Pooled fractions containing biologic activity were matched for the experimental and control groups and used to determine dose responses.
Mean cell numbers were calculated for each culture by scoring the number of fluorescently labeled astroglia or oligodendroglia found in l0 randomly selected microscopic fields (0.314 mm2). Data were expressed as fold increase in cell number when compared to PBS-treated control cultures (8) . Protein concentrations were estimated using the fluoreseamine method with bovine serum albumin standards (15) . Gel filtration provided a 250-to 500-fold purification for brain GPFs and a 100-to 300-fold purification for microglial GPFs.
RESULTS AND DISCUSSION
The events which lead to astroglial proliferation in the injured mammalian brain are not known (1, 2). Our laboratory has identified four brain-derived peptides, glia-promoting factors (GPFs), that stimulate the proliferation of specific glial populations in culture (6) (7) (8) (9) . Increasing levels of GPFs during periods of gliogenesis in the regenerating goldfish visual system and in the developing rat brain suggested that these peptides regulated glial growth in vivo (6) (7) (8) (9) . We questioned whether GPFs also played a role in mediating cellular responses in traumatized adult mammalian brain.
The damaged brain extract was fractionated using gel filtration and assayed for the presence of GPFs by incubation with mixed glial cultures grown in defined medium (8) . The supernatant contained factors that stimulated the appearance of astroglia in culture with peaks of biologic activity corresponding to GPF2 (apparent molecular mass of 9 kD) and GPF4 (3 kD) (8). 2 Adult rat cortex 10 d after stab wound injury did not contain detectable levels of the oligodendroglia-stimulating factors, GPF~ or GPFs (Figs. 1 and 2 ). Dose-response curves showed a three-to fourfold increase in the specific activities of GPF2 and GPF4 recovered from damaged brain when compared to those obtained from intact control tissue (Fig. 2) .
To determine the cellular sources of astroglia-promoting peptides, we assayed for GPFs in medium conditioned by rat brain cultures. Initial study showed that neuron-free cultures containing mixed populations of cells produced astrogliastimulating GPFs. We next examined specific gliai populations found in these cultures (oligodendroglia, astroglia, or microglia) for the production of GPF2 and GPF4 (Fig. 3) . Medium conditioned for 24 h by astroglia, oligodendroglia, or microglia did not stimulate the proliferation of astroglia (Fig. 3) . As noted earlier, glia engulf cellular debris found in injured brain tissue (1, 2). Since phagocytosis is known to activate monocyte secretion of growth factors (17), we attempted to activate the release of GPFs by incubating glia with a potent phagocytic signal, fixed S. aureus (14). We found that only "stimulated" microglia ( Fig. 3 ) released significant amounts of the astroglia-promoting factors. The microglial secretion products were further characterized by gel filtration as described for injured brain supernatants. Defined medium conditioned by activated microglia for 24 h contained astroglia-stimulating activity which corresponded to GPF2 (9 kD) and GPF4 (3 kD, Fig. 4) . Microglia did not release detectable amounts of oligodendroglia-stimu- pg protein /ml media FIGURE 2 Dose-response for GPFs found in supernatants of injured or intact rat cerebral cortex. Fractions from tissue supernatants recovered by gel filtration were screened for biologic activity as described in legend to Fig. 1 . Pooled fractions containing specific GPFs were compared to pooled matching fractions obtained from intact tissue controls. Data were expressed as degree increase in the number of astroglia or oligodendroglia. Each value represented a mean score calculated from at least five cultures. The protein concentration in pooled fractions was estimated by the fluorescamine method using bovine serum albumin standards. Increases in the specific activity of GPF2 and GPF4 were observed after injury to the rat brain. FRACTIONS FIGURE 4 Medium conditioned by activated microglia contained GPF2 and GPF4. 100,000 ameboid microglia were grown in a 75-mm 2 culture flask containing 7 ml of defined medium. Microglia were activated by addition of a suspension of 150 pl fixed 5. aureus for 24 h. Conditioned medium was concentrated to 1 ml by ultrafiltration, applied to a standardized gel filtration column, and assayed as described in legend to jug protein/ml media FIGURE 5 Dose-response curves for GPFs isolated from activated or control populations of ameboid microglia. GPFs found in media of microglia incubated with or without S. aureus were isolated by gel filtration as described in legend to Fig.  4 . Activated microglia showed a marked increase in the secretion of GPF2 and GPF4 when compared with medium from matching control preparations. Table I ). Astroglia proliferated rapidly, however, when grown together with activated microglia (G and H). Arrow (G) indicates a microglial cell atop astrocytes. Bar, 25 /~m. lating factors. Dose-response curves demonstrated that S. a u r e u s increased the secretion of GPF2 and GPF4 by three-to fivefold when compared to unstimulated microglial cultures (Fig. 5) . Further analysis of brain and microglial GPFs showed the astrogiia-stimulating factors co-purified by anion exchange chromatography (DEAE-5PW, Beckman Instruments, Inc., Palo Alto, CA; 0.5 M NaC1 gradient) and by reversephase high performance liquid chromatography (C3 column, BioRad Laboratories; 20-70% acetonitrile gradient with 10 mM trifluoroacetic acid; Giulian, D., and R. Allen, unpub-2414 THE JOURNAL OF CELL BIOLOGY -VOLUME 101, 1985 lished data). Based upon purification profiles, the specificity of biologic activities, and the stimulated release of growth factors, we concluded that activated microglia were a likely source of astroglia-stimulating peptides recovered from injured brain.
To test for a direct stimulatory action of microglia upon astrogiia, we next examined glia-glia interactions by co-culture of enriched cell populations. We monitored the proliferation of the GFA1 ~+) astroglia that were grown in defined medium for 48 h in the presence or absence of microglia (Fig. 6). There was a five-to sixfold increase in astroglial number when these cells were grown with microglia that had been stimulated with S. aureus (Table I ). Since S. aureus did not alter astroglia proliferation in the absence of microglia, we concluded that microglia acted as effector cells to promote the growth of astroglia in culture.
The implications of our in vitro data need to be considered cautiously. First, it is likely that GPFs represent only one of many regulatory mechanisms that control glial cell growth in vivo. Secondly, the ability of secreted products to influence cell growth depends not only upon the quantity and potency of the growth factor released but also the number of secretory cells and the availability of targets. Although different brain cell populations may produce GPFs in vivo, we believe ameboid microglia, which infiltrate wound sites soon after central nervous system injury, are a principal source of astrogliastimulating peptides.
Two peptides which served as mitogens for astroglia were recovered from injured brain tissue and were released in vitro by stimulated ameboid microglia. We suggest that activated microglia release factors that regulate astroglial growth and proliferation at sites of brain injury. Therapies to control microglial responses might therefore reduce astroglial scar formation associated with brain injury.
